Christopher Peetz, President and CEO at Mirum Pharmaceuticals, Inc. (MIRM), bought 7,000 shares at $14.40 ($101K) on 2021-11-24, disclosed to the SEC on 2021-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |